These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 33746755)
1. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755 [No Abstract] [Full Text] [Related]
2. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma. Guo W; Huang J; Wang N; Tan HY; Cheung F; Chen F; Feng Y Front Pharmacol; 2019; 10():1185. PubMed ID: 31649545 [TBL] [Abstract][Full Text] [Related]
3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740 [TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Zhang W; Sang S; Peng C; Li GQ; Ou L; Feng Z; Zou Y; Yuan Y; Yao M Front Oncol; 2022; 12():807718. PubMed ID: 35646655 [TBL] [Abstract][Full Text] [Related]
5. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Pan B; Pan W; Lu Z; Xia C Evid Based Complement Alternat Med; 2021; 2021():5591402. PubMed ID: 34326886 [TBL] [Abstract][Full Text] [Related]
7. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323 [TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742 [TBL] [Abstract][Full Text] [Related]
9. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro. Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502 [TBL] [Abstract][Full Text] [Related]
10. A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Zhang S; Mo Z; Zhang S; Li X Evid Based Complement Alternat Med; 2021; 2021():8947304. PubMed ID: 33688369 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology. Yang M; Yan Q; Luo Y; Wang B; Deng S; Luo H; Ye B; Wang X Front Pharmacol; 2023; 14():1016967. PubMed ID: 36744264 [No Abstract] [Full Text] [Related]
12. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003 [TBL] [Abstract][Full Text] [Related]
13. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma. Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477 [TBL] [Abstract][Full Text] [Related]
14. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology. Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, Li Y; Yang X; Wang F; Zhao J; Zhang C; Wu D; Yang B; Gao R; Zhao P; Zan Y; Su M; He Z; Liu Y; Wang J; Tang D Front Pharmacol; 2023; 14():1076815. PubMed ID: 37229244 [No Abstract] [Full Text] [Related]
16. Study on the mechanism of action of Yang AY; Liu HL; Yang YF Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068 [No Abstract] [Full Text] [Related]
17. Integrating Network Pharmacology and In Vitro Experiments for Assessing the Anti-Tumor Effects of Phyllanthus Urinaria L Anti-neoplastic Decoction in Hepatocellular Carcinoma. Wei C; Wu Z; Yang X; Jiang X; Wang L; He J; Tong G Altern Ther Health Med; 2024 May; ():. PubMed ID: 38758152 [TBL] [Abstract][Full Text] [Related]
18. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies. Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505 [TBL] [Abstract][Full Text] [Related]
19. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis. Liu K; Cao Z; Huang S; Kong F BMC Complement Med Ther; 2023 Nov; 23(1):405. PubMed ID: 37950195 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma. Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]